Cervical Pap Smear Screening: Is it really useful in Indian scenario?
Keywords:
Cervical cancer screening, Pap smear, Cervical intraepithelial neoplasia(CIN), Human papilloma virus(HPV)
Abstract
Cervical cancer is the leading cancer in women in India and worldwide. It is unique in providing long window period amenable for early detection in precancerous state through suitable screening tools. Pap smear remain important screening modality. Proper selection of screening method in community setting is a matter of debate.
Downloads
Download data is not yet available.
References
1. World Health Organization (2009) ‘The global burden of disease: Death and DALY estimates for 2004 by cause for WHO member States, 2004 Update.’ WHO: Geneva. cited 2014 Feb 26.Available from:www.who.int/healthinfo/global_burden_disease/GBD_report_2004updat.
2. Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM. GLOBOCAN 2008 v1.2: Cancer incidence and mortality worldwide: IARC CancerBase No. 10. Lyon (France): IARC Press; 2010. Availablfrom: http://globocan.iarc.fr.Accessed: Feb 26, 2014.
3. Cole P, Morrison AS. Basic issues in population screening for cancer. J Natl Cancer Inst. 1980 May;64(5): 1263-72. [PubMed]
4. Walboomers JM, Jacobs MV, Manos MM, Bosch FX, Kummer JA, Shah KV, Snijder PJ, Peto J, Meijer CJ, Munoz N. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol.1999 Sep; 189(1): 12-19.
5. Almonte M, Ferreccio C, Winkler JL, Cuzick J, Tsu V, Robles, Takahashi R, Sasieni P. Cervical screening by visual inspection, HPV testing, liquid-based and conventional cytology in Amazonian Peru. Int J Cancer. 2007 Aug; 121(4): 796-802. [PubMed]
6. Cuzick J, Clavel C, Petry KU, Meijer CJ, Hoyer H, Ratnam S, Szarewski A, Birembaut P, Kulasingam S, Sasieni P, Iftner T. Overview of the European and North American studies on HPV testing in primary cervical cancer screening. Int J Cancer. 2006 Sep 1; 119(5): 1095-101. [PubMed]
7. Sankaranarayanan R, Thara S, Sharma A, R oy C, Shastri S, Mahe C, Muwonge R, Fontaniere B. Accuracy of conventional cytology: results from a multicentre screening study in India. J Med Screen. 2004; 11(2): 77-84. [PubMed]
8. Sarian LO, Derchain SF, Naud P, Roteli Martin C, Longatto-FilhoA, Tatti S, BrancaM, Erzen M, Serpa-Hammes L,MatosJ, Gontijo R, Braganca JF, Lima TP, Maeda MY, Lorincz A, Dores GB, Costa S, Syrjanen S, Syrjanem K. Evaluation of visual inspection with acetic acid (VIA), Lugol’s iodine (VILI), cervical cytology and HPV testing as cervical screening tools in Latin America. This report refers to partial results from the LAMS (Latin AMerican Screening) study. J Med Screen. 2005; 12(3): 142-9.
9. Belinson J, Qiao Y, Pretorius R, Zhang W, Keaton K, ElsonP, Fischer C, Lorincz A, Zahniser D, Wilbur D, Pan Q, Li L, Biscotti C, Dawson A, Li A, Wu L, Ling Y, Ma CP, Yang CP. Prevalence of cervical cancer and feasibility of screening in rural China: a pilot study for the Shanxi Province Cervical Cancer Screening Study. Int J Gynecol Cancer.1999 Sep; 9(5): 411-7.
10. Megevand E, Denny L, Dehaeck K, Soeter R, Bloch B. Acetic acid visualization of the cervix: an alternative to cytologic screening. Obstet Gynecol. 1996 Sep; 88(3): 383-6. [PubMed]
11.Sankaranarayanan R, Basu P, Wesley RS, Mahe C, Keita N, Mbalawa CC, Sharma r, Dolo A, Shastri SS, Nacoulma M, Nayama M, Somanathan T, Lucas Z, Muwange R, Frappart L, Parkin DM. Accuracy of visual screening for cervical neoplasia: Results from an IARC multicentre study in India and Africa. Int J Cancer. 2004 July 20; 110(6): 907-13.
12. Sankaranarayanan R, Nene BM, Dinshaw KA, Mahe C, Jayant K, Shastri SS, Malvi SG, Chinoy r, Kelkar R, Budukh AM, Keskar V, Rajeshwarkar R, Muwonge R, Kane s, Parkin DM, Chauhan mk, Desai S, Fontaniere B, Frapport L, Kothari A, Lucas E, Panse N. A cluster randomized controlled trial of visual, cytology and human papillomavirus screening for cancer of the cervix in rural India. Int J Cancer. 2005 Sep 10; 116(4): 617-623.
13. Sauvaget C, Fayette JM, Muwonge R, Wesley R, Sankarnarayanan R. Accuracy of visual inspection with acetic acid for cervical cancer screening. Int J Gynaecol Obstet. 2011 April; 113(1): 14-24.
14. Sankaranarayanan R, Gaffikin L, Jacob M, Wesley R, Sellers J, Robles S. A critical assessment of screening methods for cervical neoplasia. Int J Gynaecol Obstet. 2005 May; 89 Suppl 2: S4-S12. [PubMed]
15. Muwonge R, Manuel MG, Filipe AP,Dumas JB, Frank MR, Sankarnarayanan R. Visual screening for early detection of cervical neoplasia in Angola. Int J Gynaecol Obstet. 2010 Oct; 111(1): 68-72. [PubMed]
16. Ngoma T, Muwonge R, Mwaiselage J, Kawegere J, Bukori P, Sankarnarayanan R. Evaluation of cervical visual inspection screening in Dar es Salaam, Tanzania. Int J Gynaecol Obstet. 2010 May; 109(2): 100-4. [PubMed]
17. Qiao YL, Sellors JW, Eder PS, Bao YP, Lim JM, Zhao FH, Weigl b, Zhang WH, Peck RB, Li L, Chen F, Pan QJ, Lorincz AT. A new HPV-DNA test for cervical-cancer screening in developing regions: a cross-sectional study of clinical accuracy in rural China. Lancet Oncol. 2008 Oct; 9(10): 929-36.
2. Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM. GLOBOCAN 2008 v1.2: Cancer incidence and mortality worldwide: IARC CancerBase No. 10. Lyon (France): IARC Press; 2010. Availablfrom: http://globocan.iarc.fr.Accessed: Feb 26, 2014.
3. Cole P, Morrison AS. Basic issues in population screening for cancer. J Natl Cancer Inst. 1980 May;64(5): 1263-72. [PubMed]
4. Walboomers JM, Jacobs MV, Manos MM, Bosch FX, Kummer JA, Shah KV, Snijder PJ, Peto J, Meijer CJ, Munoz N. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol.1999 Sep; 189(1): 12-19.
5. Almonte M, Ferreccio C, Winkler JL, Cuzick J, Tsu V, Robles, Takahashi R, Sasieni P. Cervical screening by visual inspection, HPV testing, liquid-based and conventional cytology in Amazonian Peru. Int J Cancer. 2007 Aug; 121(4): 796-802. [PubMed]
6. Cuzick J, Clavel C, Petry KU, Meijer CJ, Hoyer H, Ratnam S, Szarewski A, Birembaut P, Kulasingam S, Sasieni P, Iftner T. Overview of the European and North American studies on HPV testing in primary cervical cancer screening. Int J Cancer. 2006 Sep 1; 119(5): 1095-101. [PubMed]
7. Sankaranarayanan R, Thara S, Sharma A, R oy C, Shastri S, Mahe C, Muwonge R, Fontaniere B. Accuracy of conventional cytology: results from a multicentre screening study in India. J Med Screen. 2004; 11(2): 77-84. [PubMed]
8. Sarian LO, Derchain SF, Naud P, Roteli Martin C, Longatto-FilhoA, Tatti S, BrancaM, Erzen M, Serpa-Hammes L,MatosJ, Gontijo R, Braganca JF, Lima TP, Maeda MY, Lorincz A, Dores GB, Costa S, Syrjanen S, Syrjanem K. Evaluation of visual inspection with acetic acid (VIA), Lugol’s iodine (VILI), cervical cytology and HPV testing as cervical screening tools in Latin America. This report refers to partial results from the LAMS (Latin AMerican Screening) study. J Med Screen. 2005; 12(3): 142-9.
9. Belinson J, Qiao Y, Pretorius R, Zhang W, Keaton K, ElsonP, Fischer C, Lorincz A, Zahniser D, Wilbur D, Pan Q, Li L, Biscotti C, Dawson A, Li A, Wu L, Ling Y, Ma CP, Yang CP. Prevalence of cervical cancer and feasibility of screening in rural China: a pilot study for the Shanxi Province Cervical Cancer Screening Study. Int J Gynecol Cancer.1999 Sep; 9(5): 411-7.
10. Megevand E, Denny L, Dehaeck K, Soeter R, Bloch B. Acetic acid visualization of the cervix: an alternative to cytologic screening. Obstet Gynecol. 1996 Sep; 88(3): 383-6. [PubMed]
11.Sankaranarayanan R, Basu P, Wesley RS, Mahe C, Keita N, Mbalawa CC, Sharma r, Dolo A, Shastri SS, Nacoulma M, Nayama M, Somanathan T, Lucas Z, Muwange R, Frappart L, Parkin DM. Accuracy of visual screening for cervical neoplasia: Results from an IARC multicentre study in India and Africa. Int J Cancer. 2004 July 20; 110(6): 907-13.
12. Sankaranarayanan R, Nene BM, Dinshaw KA, Mahe C, Jayant K, Shastri SS, Malvi SG, Chinoy r, Kelkar R, Budukh AM, Keskar V, Rajeshwarkar R, Muwonge R, Kane s, Parkin DM, Chauhan mk, Desai S, Fontaniere B, Frapport L, Kothari A, Lucas E, Panse N. A cluster randomized controlled trial of visual, cytology and human papillomavirus screening for cancer of the cervix in rural India. Int J Cancer. 2005 Sep 10; 116(4): 617-623.
13. Sauvaget C, Fayette JM, Muwonge R, Wesley R, Sankarnarayanan R. Accuracy of visual inspection with acetic acid for cervical cancer screening. Int J Gynaecol Obstet. 2011 April; 113(1): 14-24.
14. Sankaranarayanan R, Gaffikin L, Jacob M, Wesley R, Sellers J, Robles S. A critical assessment of screening methods for cervical neoplasia. Int J Gynaecol Obstet. 2005 May; 89 Suppl 2: S4-S12. [PubMed]
15. Muwonge R, Manuel MG, Filipe AP,Dumas JB, Frank MR, Sankarnarayanan R. Visual screening for early detection of cervical neoplasia in Angola. Int J Gynaecol Obstet. 2010 Oct; 111(1): 68-72. [PubMed]
16. Ngoma T, Muwonge R, Mwaiselage J, Kawegere J, Bukori P, Sankarnarayanan R. Evaluation of cervical visual inspection screening in Dar es Salaam, Tanzania. Int J Gynaecol Obstet. 2010 May; 109(2): 100-4. [PubMed]
17. Qiao YL, Sellors JW, Eder PS, Bao YP, Lim JM, Zhao FH, Weigl b, Zhang WH, Peck RB, Li L, Chen F, Pan QJ, Lorincz AT. A new HPV-DNA test for cervical-cancer screening in developing regions: a cross-sectional study of clinical accuracy in rural China. Lancet Oncol. 2008 Oct; 9(10): 929-36.
CITATION
DOI: 10.17511/ijmrr.2014.i01.01
Published: 2014-02-28
How to Cite
1.
Prasad Patel N, Gedam DS. Cervical Pap Smear Screening: Is it really useful in Indian scenario?. Int J Med Res Rev [Internet]. 2014Feb.28 [cited 2024Nov.8];2(1):1-. Available from: https://ijmrr.medresearch.in/index.php/ijmrr/article/view/49
Section
Editorial
OAI - Open Archives Initiative
